By Canadian Press

Novavax COVID-19 vaccine gets approval for use in Canada

Feb 17, 2022 | 10:10 AM

The Novavax COVID-19 vaccine has been approved for use in Canada.

The vaccine, which is protein-based, is the first of its kind to get approval in the country.

Experts say a non-mRNA vaccine could win over some vaccine-hesitant people who have still not received a dose of a COVID-19 vaccine.

The U.S. company Novavax Inc. submitted its package for approval to Health Canada last November.

The Novavax shots have already been cleared for use in other countries, including Britain, Europe, Australia, and Singapore.

Nighttime construction on Hwy 3 in Lethbridge starts April 17

Apr 17, 2025

SASHA launches #BuyABed fundraiser to support vulnerable Lethbridge residents

Apr 04, 2025

$20K grants available: TELUS STORYHIVE Pan-Asian Edition opens applications April 1

Mar 18, 2025

Ottawa also signed a deal last year to produce the Novavax vaccine in Canada and a manufacturing plant was constructed in Montreal.

More coming…

The Canadian Press

For local news delivered daily to your email inbox, subscribe for free to the Lethbridge News Now newsletter here. You can also download the Lethbridge News Now mobile app in the Google Play and the Apple App Stores.